DHG: Explanation for business result in Q3/2014 DHG Pharmaceutical Joint Stock Company has explained the decrease in profit of Quarter 3/2014 compared to Quarter 3/2013:
By: million dongs
|
09
months of 2014
|
09
months of 2013
|
Different
|
Quarter
3
|
09 months
|
Quarter
3
|
09
months
|
Quarter
3
|
09
months
|
Value
|
Ratio
|
Value
|
Ratio
|
Net
revenue
|
872,553
|
2,440,312
|
736,945
|
2,117,709
|
135,608
|
18.40
|
322,604
|
15.23
|
Profit
before tax
|
147,966
|
503,527
|
247,077
|
561,915
|
-99,111
|
-40.11
|
-58,387
|
-10.39
|
Profit
after tax
|
117,087
|
412,451
|
190,029
|
447,711
|
-72,942
|
-38.38
|
-35,260
|
-7.88
|
Reason:
- Revenue in Quarter 3/2014 increased
18.4%. In the first 09 months of 2014, revenue increased 15.23%. -
In
2013, the firm made science and technology funds by 5% of
profit after tax. - In Quarter 3/2013, net revenue from transferring Eugica
trademark (VND122 billion), leading to profit in Quarter 3/2014 and in the
first 09 months of 2014 were less than 2013.
HOSE
|